{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:49Z","timestamp":1761005809223,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Science, Culture, and Sports of Japan","doi-asserted-by":"crossref","award":["21390267","25870456"],"award-info":[{"award-number":["21390267","25870456"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Committee of CNS\u00a0Degenerative Diseases"},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:05:53Z","timestamp":1412993153000},"page":"2646-2653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term Amelioration of Telmisartan on Metabolic Syndrome-related Molecules in Stroke-resistant Spontaneously Hypertensive Rat after Transient Middle Cerebral Artery Occlusion"],"prefix":"10.1016","volume":"23","author":[{"given":"Kentaro","family":"Deguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhai","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syoichiro","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.011","article-title":"A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients","volume":"22","author":"Deguchi","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.me.44.020193.001005","article-title":"Role of insulin resistance in human disease (syndrome X): an expanded definition","volume":"44","author":"Reaven","year":"1993","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.1989.00390070054005","article-title":"The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension","volume":"149","author":"Kaplan","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181b59bf3","article-title":"Treatment of vascular risk factors is associated with slower decline in Alzheimer disease","volume":"73","author":"Deschaintre","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib5","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib8","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1073\/pnas.93.22.12490","article-title":"Cross-talk between the insulin and angiotensin signaling systems","volume":"93","author":"Velloso","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/jpet.109.157099","article-title":"An adipose tissue-independent insulin-sensitizing action of telmisartan: a study in lipodystrophic mice","volume":"331","author":"Rong","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib11","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1248\/bpb.b12-00387","article-title":"Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors","volume":"35","author":"Shindo","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01616412.1992.11740089","article-title":"Differential expression of heat shock protein 70 gene between the cortex and caudate after transient focal cerebral ischaemia in rats","volume":"14","author":"Abe","year":"1992","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.expneurol.2007.11.028","article-title":"Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure","volume":"210","author":"Kumai","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3317\/jraas.2001.013","article-title":"Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats","volume":"2","author":"Wienen","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3317\/jraas.2007.017","article-title":"Renoprotective effects of telmisartan in the 5\/6 nephrectomised rats","volume":"8","author":"Tsunenari","year":"2007","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib17","article-title":"Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR rat after tMCAO","author":"Kurata","year":"2014","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.33549\/physiolres.930380","article-title":"Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension","volume":"52","author":"Pravenec","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0047-6374(01)00362-1","article-title":"The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?","volume":"123","author":"Sabbatini","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.amjhyper.2006.09.016","article-title":"Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity","volume":"20","author":"Mori","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12325-011-0040-2","article-title":"Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)","volume":"28","author":"Mori","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.274.5290.1151","article-title":"Does leptin contribute to diabetes caused by obesity?","volume":"274","author":"Taylor","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib26","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1016\/S0021-9258(18)54714-1","article-title":"Transcriptional repression of the GLUT4 and C\/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha","volume":"266","author":"Stephens","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.274.5290.1185","article-title":"Modulation of insulin activities by leptin","volume":"274","author":"Cohen","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib29","doi-asserted-by":"crossref","first-page":"R674","DOI":"10.1152\/ajpregu.00643.2002","article-title":"Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?","volume":"285","author":"Cediel","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.HYP.35.1.501","article-title":"Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension","volume":"35","author":"Ghiadoni","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib31","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00005344-199811000-00017","article-title":"Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats","volume":"32","author":"Rizzoni","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00004872-199715060-00007","article-title":"Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril","volume":"15","author":"Rodrigo","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib34","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.brainres.2011.01.062","article-title":"Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat","volume":"1382","author":"Kawai","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib36","doi-asserted-by":"crossref","first-page":"H111","DOI":"10.1152\/ajpheart.01061.2003","article-title":"Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB\/IkappaB system","volume":"288","author":"Sanz-Rosa","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib37","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","article-title":"Antidiabetic mechanisms of\u00a0angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system","volume":"22","author":"Kurtz","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib38","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.051","article-title":"Telmisartan reduces progressive oxidative stress and phosphorylated \u03b1-synuclein accumulation in SHR-SR rats after tMCAO","volume":"23","author":"Sato","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/diab.28.4.287","article-title":"Downregulation of insulin receptors in obese man","volume":"28","author":"Wigand","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib40","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/hr.2012.105","article-title":"Effects of telmisartan on the cerebral circulation of hypertensive patients with chronic-stage stroke","volume":"35","author":"Deguchi","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.06.012_bib41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714002948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714002948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:39:28Z","timestamp":1760942368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305714002948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1052305714002948"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.06.012","relation":{},"ISSN":["1052-3057"],"issn-type":[{"type":"print","value":"1052-3057"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Amelioration of Telmisartan on Metabolic Syndrome-related Molecules in Stroke-resistant Spontaneously Hypertensive Rat after Transient Middle Cerebral Artery Occlusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}